Stay updated on IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial
Sign up to get notified when there's something new on the IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial page.

Latest updates to the IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check38 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check88 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check103 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
Stay in the know with updates to IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial page.